RxDoctor Payments Data

Do-Yeon Cho

Otolaryngology · Birmingham, ALNPI 1104051408

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (41.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Sanofi at 25.5% of the total. 2025 is the largest year on record at $9,654, 4.9 times the $1,963 reported in 2019. Among otolaryngology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,408in general payments, 2019–2025

Across 138 payments — averaging $140.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$5K
  • Medtronic$4K
  • Aerin Medical Inc.$3K
  • Regeneron Healthcare Solutions, Inc.$2K
  • Optinose US, Inc.$2K
  • 3-d Matrix, Inc.$919
  • plus $2K from 11 others
$49,520in research payments, 2019–2025

Across 4 payments — averaging $12,380 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$41K
  • Sanofi US Services Inc.$7K
  • Roche Products Limited$2K

What the payments were for

  • Consulting fees$4,53623%
  • Travel & lodging$6,77235%
  • Food & beverage$8,10042%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,408 in reported general payments places this provider in the 95th percentile of 155 otolaryngology providers in Alabama.

See all otolaryngology providers in Alabama

Medicare billing

Part B allowed, 2024
$38,422
Medicare patients
154
Services billed
473

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab32$116,183
Ipratropium Bromide68$2,882
Azelastine Hcl47$1,610
Desloratadine15$1,157
Fluticasone Propionate57$818
Clarithromycin11$197
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$123
Doxycycline Hyclate13$111

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →